Trek Financial LLC boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 105.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 80,717 shares of the exchange traded fund’s stock after purchasing an additional 41,441 shares during the quarter. Trek Financial LLC owned about 0.12% of SPDR S&P Biotech ETF worth $12,727,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Angeles Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth about $28,000. Root Financial Partners LLC acquired a new stake in SPDR S&P Biotech ETF during the third quarter worth about $31,000. Axiom Investment Management LLC acquired a new stake in SPDR S&P Biotech ETF during the first quarter worth about $26,000. Morling Financial Advisors LLC bought a new position in SPDR S&P Biotech ETF during the second quarter valued at about $36,000. Finally, JFS Wealth Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 136.5% in the 2nd quarter. JFS Wealth Advisors LLC now owns 272 shares of the exchange traded fund’s stock valued at $43,000 after acquiring an additional 157 shares in the last quarter.
SPDR S&P Biotech ETF Price Performance
XBI opened at $155.98 on Monday. The stock has a market capitalization of $10.72 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a one year low of $106.30 and a one year high of $169.89. The company’s 50 day simple moving average is $156.60 and its 200-day simple moving average is $141.58.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- SK hynix Says Memory Demand Beats Supply Through 2030—What It Means for Micron and SanDisk
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
